By Michael Gwarisa
Ivory Medical, a leading Zimbabwean healthcare company, has launched CannaQure, a new line of cannabis-based medicinal products, at a high-profile event held at the Rainbow Towers Hotel in Harare. This marks a groundbreaking step in Zimbabwe’s healthcare landscape as Ivory Medicinal introduces cannabis-based solutions designed to relieve symptoms of chronic pain, stress, and sleep issues.
CannaQure products, rich in Cannabidiol (CBD) and free from psychoactive effects, offer Zimbabweans a natural, alternative path to wellness without inducing a “high.” Developed to adhere to the Medicines Control Authority of Zimbabwe’s rigorous safety and quality standards, CannaQure aims to support those looking for reliable, science-backed options alongside traditional treatments.
This launch represents a milestone in Zimbabwe’s healthcare evolution,” said Nash Kadzinga, General Manager of Ivory Medical.
“CannaQure provides a safe, effective, and accessible option for patients seeking alternative treatments. We’re excited to offer Zimbabweans a dependable solution grounded in both science and nature.”
The event included presentations from healthcare experts, emphasizing the proven benefits of medicinal cannabis and its acceptance worldwide. Ivory Medical now at the forefront of Zimbabwe’s medicinal cannabis industry, seeks to dispel misconceptions about cannabis through education and outreach, partnering with health providers to improve understanding of its therapeutic potential.
With a mission rooted in quality and transparency, Ivory Medical envisions a future where alternative treatments play a vital role in the health and wellness of Zimbabweans, empowering patients with safe, effective choices.
